Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Tumor Profiling Market Growth Performance Trended Historically, And What Lies Ahead?

Over the last few years, the size of the tumor profiling market has seen swift expansion. The market is projected to burgeon from $10.16 billion in 2024 to $11.18 billion in 2025, marking a compound annual growth rate (CAGR) of 10.0%. Factors like rising incidences of cancer, soaring demand for individualized treatments, increased spending on healthcare, growing utilization of companion diagnostics, and a heightened awareness for early detection of cancer have fueled the growth in the historical period.

A significant increase in the size of the tumor profiling market can be anticipated in the coming years, with projections indicating it will rise to $16.37 billion in 2029 at a compound annual growth rate of 10.0%. Multiple factors influencing this growth trend are expected, including the increasing use of liquid biopsy methods, a surge in investment concerning cancer research and development, a rise in aging population, expanding use of targeted therapies, as well as growing cancer research collaborations. Key shifts and trends expected during this forecast period involve a move towards companion diagnostics, an increase in multi-gene testing, next-generation sequencing tech upgrades, artificial intelligence’s introduction into cancer diagnostics, and advances in tumor profiling technologies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24420&type=smp

Which Factors and External Forces Are Driving Demand in the Tumor Profiling Market?

The upward trend in the demand for tailor-made medical treatments is anticipated to catalyze the expansion of the tumor profiling market. Personalized medicine is a method of customizing healthcare procedures based on the unique traits of each patient. The driving factor for this surge is patients’ desire for more specific treatments that offer improved results and fewer side effects in comparison to conventional treatments. Tumor profiling facilitates personalized medicine by identifying particular genetic changes and biomarkers in a patient’s tumor, which allow for targeted treatments and lessen side effects. For example, a report from the Personalized Medicine Coalition, a US-based organization committed to promoting personalized medicine, revealed in February 2024 that more than a third of all new drug approvals in 2023 were personalized medicines. This was the fourth year in a row for such a pattern. Consequently, the rising demand for personalized medicine is propelling the growth of the tumor profiling market.

Which Segments in the Tumor Profiling Offer the Most Growth?

The tumor profilingmarket covered in this report is segmented –

1) By Technique: Genomics; Proteomics; Epigenetics; Metabolomics

2) By Technology: Sequencing Techniques; Quantitative Polymerase Chain Reaction (qPCR); Immunohistochemistry; In Situ Hybridization (ISH); Microarray

3) By Application: Personalized Cancer Medicine; Oncological Diagnostics; Research

Subsegments:

1) By Genomics: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Microarrays; Sanger sequencing

2) By Proteomics: Mass Spectrometry (MS); Protein Microarrays; Immunohistochemistry (IHC); Western Blotting

3) By Epigenetics: DNA Methylation Analysis; Chromatin Immunoprecipitation Sequencing (ChIP-seq); Histone Modification Profiling; Non-Coding RNA Analysis

4) By Metabolomics: Nuclear Magnetic Resonance (NMR) Spectroscopy; Gas Chromatography-Mass Spectrometry (GC-MS); Liquid Chromatography-Mass Spectrometry (LC-MS); Capillary Electrophoresis-Mass Spectrometry (CE-MS)

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=24420&type=smp

What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Tumor Profiling Market?# Market?

North America was the largest region in the tumor profiling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor profiling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Cutting-Edge Market Trends Are Expected to Drive theTumor Profiling Market’s Growth?

Leading enterprises within the tumor profiling sector are concentrating their efforts on the evolution of advanced solutions, such as diagnostic systems powered by artificial intelligence (AI) to improve precision and effectiveness in cancer therapy. The usage of AI encompasses advanced computational applications to evaluate intricate genomic, proteomic, and clinical data, facilitating quicker diagnosis, tailored treatment regimens, and improved supervision of disease progression. For instance, Panakeia Technologies LTD, a company rooted in the UK that specializes in AI-infused software for cancer detection and therapy, rolled out PANProfiler Colon in January 2025. This AI-integrated software solution was specifically engineered to profile central molecular biomarkers like microsatellite instability (MSI) and mismatch repair insufficiency (dMMR). It does this by using H and E-stained imagery of colon cancer tissue samples. This innovative digital tool paves the way for fast and accurate molecular profiling of tumors, fundamental for diagnosing colorectal cancer, pinpointing instances of Lynch syndrome, and aiding in the formulation of personalized treatment choices.

View the full report here:

https://www.thebusinessresearchcompany.com/report/tumor-profiling-global-market-report

What Are the Key Elements That Define the Tumor Profiling Market?

Tumor profiling refers to a set of techniques used to analyze and characterize the genetic and molecular features of a tumor, which helps to identify specific mutations, gene expression patterns, and other molecular characteristics of cancer cells, and this tumor profiling can provide crucial information about the biology of a particular tumor, guide treatment decisions, and inform personalized therapies.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24420

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model